North America In Vitro Diagnostics Market 2019 by Technology Types, Applications, End-Users, Revenue, Cost, Demand, Trends and Investment Opportunities to 2025

This market research report includes a detailed segmentation of the North America in vitro diagnostics market – by technology types (clinical chemistry, molecular diagnostics, immunoassay, clinical microbiology, coagulation, hematology, and others), by applications and forecast up to 2025

Dallas , United States - August 24, 2019 /MarketersMedia/ —

The North America In Vitro Diagnostics market will grow at a CAGR of 5.17% during the forecast period 2019–2025. The market has witnessed steady growth in the past few years, and the advancements in technology with the introduction of innovative products have increased the adoption of in vitro diagnostics products in the market. The market is fueled by the increasing incidence of lifestyle and chronic diseases, rising adoption of point-of-care testing (POCT), the upsurge in the biomarker-based tests, and growing significance of companion diagnostics.

Request a sample of this report @

The market continues to grow, and in vitro diagnostics is one of the most widely used techniques for screening, diagnosis, treatment, and monitoring purposes. The field is getting revolutionized with the advancement in technology. Vendors are focusing on new product launches, approvals, and targeting toward end-user’s perspective. The market generates revenue from the key players operating in this field, and few of them include Abbott Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Danaher Corporation, and Sysmex Corporation.

The US accounted for the largest share of the North America in vitro diagnostics market in 2018 and “others” segment is expected to grow a high CAGR during the forecast period. According to the estimation of the National Cancer Institute, in the US, around 1.6 million new cases of cancer were diagnosed, and 595,690 people have died due to cancer in 2016. In 2016, Canada had an estimated 202,400 new cases of cancer and nearly 78,000 deaths according to the Canadian Cancer Society. Lifestyle-related diseases such as diabetes and heart diseases are becoming a major threat to the population across the world with 425 million people suffering from diabetes. Cardiovascular disease (CVD) accounts for approximately 800,000 deaths in the US and on an average, one person dies from CVD every 40 seconds in the US. Favorable reimbursement policies, the presence of dominant market vendors in the country, increased awareness among patients, availability of government funds, and increasing adoption of molecular diagnostics make the US a dominant shareholder in the market.

By Technology Types:
• Clinical Chemistry
• Molecular Diagnostics
• Immunoassay
• Clinical Microbiology
• Coagulation
• Hematology
• Others

Make an enquiry of this report @

In 2018, the clinical chemistry segment occupied the largest share, and molecular diagnostics segment is expected to grow at a high CAGR during the forecast period. Clinical chemistry includes metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile, thyroid function panel, and specialty chemistry tests. Increased technological advancements such as next-generation sequencing & polymerase chain reaction and growing number of strategic deals are likely to propel the molecular diagnostics segment during the forecast period.

By Applications:
• Oncology
• Infectious Disease
• Diabetes
• Cardiology
• Nephrology
• Autoimmune Disease
• Others

The infectious disease segment occupied a major market share in 2018, and the oncology segment is predicted to hold a significant share during the forecast period. Increase in the prevalence of the disease such as tuberculosis & pneumonia and growing healthcare awareness among the population make the segment a dominant shareholder.

By End-users:
• Hospitals
• Laboratories
• Home Care
• Academic & Research Institutes
• Others

Hospitals occupied a significant market share in 2018, and hospitals and laboratory segments are expected to dominate the market for the next few years.

By Country:
• US
• Others

The US occupied a significant market share in 2018, and the “others” segment is expected to grow at a high CAGR during the forecast period. The increased technological advancement and higher GDP of the nation make “others”, that includes Canada and Mexico, the fastest growing segment during the forecast period.

In Vitro Diagnostics Market Research Competitive Analysis – The in vitro diagnostics market has massive growth opportunities in the North American region. The advancements of technology will increase competition among vendors. The diagnostics and biotechnology continuously focus on the market due to an increase in lifestyle and chronic diseases. This has resulted in approvals and collaborations related to in-vitro diagnosis in recent years. For instance, Roche launched VENTANA pan-TRK (EPR17341) Assay to detect tropomyosin receptor kinase (TRK) to diagnose multiple solid tumor types at the end of 2018. FDA has approved F1CDx test to identify genetic alterations in tumors in December 2017. The genomic test can identify cancer-related alterations in 324 genes in any type of solid tumor. FDA approved Ortho Clinical Diagnostics VITROS Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator for use on the VITROS 5600 Integrated System in 2018. This 4th generation test can detect both HIV-1 and HIV-2 antibodies as well as the p24 antigen, which provides a shorter diagnostic window compared to 3rd generation assays. In late 2018, Precision for Medicine acquired ApoCell, a next-generation lab specializing in the identification and analysis of biomarkers. In addition, other leading players are focusing on hugely investing in R&D activities to develop new products to attain the maximum share in the market.

Key Vendors:
• Abbott Laboratories
• F. Hoffmann-La Roche (Roche)
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Sysmex Corporation
• bioMerieux S.A.
• Becton Dickinson and Company
• Bio-Rad Laboratories
• Qiagen N.V.
• Siemens Healthineers
• Ortho Clinical Diagnostics (Carlyle Group)

Major Point from Table of Content:
1 Industry Outlook
2 Report Outline
3 Market Snapshot
4 Market Outlook
5 Market Characteristics
6 Technology Types: Market Size and Analysis
7 Applications: Market Size and Analysis
8 End-users: Market Size and Analysis
9 Country: Market Size and Analysis
10 Competitive Landscape
11 Vendors Profile
11.1 F. Hoffmann-La Roche Ltd.
11.2 Thermo Fisher Scientific Inc.
11.3 Abbott Laboratories
11.4 Danaher Corporation
11.5 Sysmex Corporation
12 Companies to Watch For

Browse the complete report @

About Us:
Orbis Research ( is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A.
Phone: +1 (214) 884-6817; +912064101019

Source URL:

Source: MarketersMedia

Release ID: 88911773

Latest News

Indiana lawmakers seek probe of ex-abortion doctor's clinics

Sep 17, 2019

INDIANAPOLIS — Indiana's attorney general said Monday that he will work with his Illinois counterpart to investigate what he called the "grisly discovery" of more than 2,000 medically preserved fetal remains at the Illinois home of a late doctor who performed abortions in Indiana. Republican Attorney General Curtis Hill said he and Democratic Illinois Attorney General Kwame Raoul have "agreed to work together" as Hill's office coordinates an investigation of the remains found at the home of Dr. Ulrich Klopfer, who died Sept. 3. "The grisly discovery of these fetal remains at the Illinois home of a deceased abortion doctor...

The Latest: Indiana, Illinois AGs to probe fetal remains

Sep 17, 2019

INDIANAPOLIS — The Latest on the discovery of fetal remains at the Illinois home of a former Indiana abortion doctor (all times local): 4:30 p.m. Indiana's attorney general says he'll work with his Illinois counterpart to investigate last week's discovery of more than 2,000 medically preserved fetal remains at the Illinois home of a late doctor who performed abortions in Indiana. Republican Indiana Attorney General Curtis Hill said in a statement Monday that he conferred over the weekend with Democratic Illinois Attorney General Kwame Raoul and they "agreed to work together" as Hill's office coordinates an investigation into the remains...

No new measles cases reported in fading US outbreak

Sep 17, 2019

NEW YORK — The nation's worst measles epidemic in 27 years could be in its final stages as a week went by with no new reported cases. "To get to zero is tremendously encouraging," said Jason Schwartz, a Yale University expert on vaccination policy. The current epidemic emerged about a year ago and took off earlier this year, with most of the cases reported in Orthodox Jewish communities in and around New York City. It started with travelers who had become infected overseas but spread quickly among unvaccinated people. In the spring, 70 or more new cases were being reported...

The Latest: Michigan governor supports striking GM workers

Sep 17, 2019

DETROIT — The Latest on the United Auto Workers strike against General Motors (all times local): 12:30 p.m. Michigan Gov. Gretchen Whitmer is supporting autoworkers who are striking against General Motors. The Democrat on Monday visited United Auto Workers members picketing outside the Lansing Grand River plant, blocks from the state Capitol building. Photos her office posted to social media showed her shaking hands and delivering doughnuts. Spokeswoman Tiffany Brown says Whitmer is closely monitoring the strike and supports working peoples' rights to negotiate together for better wages, benefits, working conditions and more time to spend with their families. More...

Many US women say 1st sexual experience was forced in teens

Sep 17, 2019

CHICAGO — The first sexual experience for 1 in 16 U.S. women was forced or coerced intercourse in their teens. That's according to a study published Monday that says those encounters may have had lasting health consequences. The authors say the experiences amount to rape, but they relied on a national survey that didn't use the word in asking about forced sex. It happened to almost 7 percent of women surveyed, they were age 15 on average the man was often several years older. Affected women had more sex partners, unwanted pregnancies and abortions, and more reproductive health problems than...

About Us

Travel Leisure Mag is New York City’s travel and lifestyle online magazine with the vision of creating a unique blend of valuable and quality travel experience to the readers. We trust that you will enjoy this experience.

Contact us: sales[at]